Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
20 Oct 2026

Insmed Incorporated reported A director or senior management change or compensation event

Insmed Incorporated filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

5 Oct 2026

Insmed Incorporated reported A director or senior management change or compensation event

Insmed Incorporated filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

15 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Insmed Incorporated.

6 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Insmed Incorporated.

6 Aug 2026

Insmed Incorporated reported Operating or financial results

Insmed Incorporated filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis
Cash and equivalents (USD)$544.77M
Total assets (USD)$2.10B
Total liabilities (USD)$1.35B
Shareholders' equity (USD)$757.49M
Long-term debt (USD)$543.51M
Debt due within a year (USD)$224.45M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
QuarterRevenue (USD)Operating incomeNet incomeDiluted EPS (USD)Filed
Q2 2026$425.49M−$1.55M−$13.24M−$0.0610-Q · 6 Aug 2026
Q1 2026$305.96M−$153.32M−$163.56M−$0.7610-Q · 7 May 2026
Q4 2025$263.84M−$319.75M−$328.49MUnavailable10-K · 19 Feb 2026
Q3 2025$142.34M−$366.01M−$370.02M−$1.7510-Q · 30 Oct 2025
Q2 2025$107.42M−$312.88M−$321.69M−$1.7010-Q · 7 Aug 2025
Q1 2025$92.82M−$248.14M−$256.58M−$1.4210-Q · 8 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy
Target: $196.42
105.4% upside potential
📈
Strong Buy
Unavailable
👍
Buy
20
⏸️
Hold
1
📉
Sell
0
21 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 169.00–243.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
19
Oct 2026
Koppikar Utpal
Director
Grant or award
Unavailable per share
6,139 shares
SEC Form 4
19
Oct 2026
Hudson Paul
Director
Grant or award
Unavailable per share
6,139 shares
SEC Form 4
9
Sep 2026
Brennan David R
Director
Open-market sale
$124.00 per share
25,000 shares
SEC Form 4
17
Aug 2026
SHAROKY MELVIN MD
Director
Open-market sale
$127.53 per share
5,000 shares
SEC Form 4
10
Aug 2026
Adsett Roger
Chief Operating Officer
Option exercise
$20.45 per share
239,850 shares
SEC Form 4
10
Aug 2026
Adsett Roger
Chief Operating Officer
Open-market sale
$133.27 per share
239,850 shares
SEC Form 4
6
Aug 2026
Flammer Martina M.D.
Chief Medical Officer
Option exercise
$21.20 per share
27,173 shares
SEC Form 4
6
Aug 2026
Flammer Martina M.D.
Chief Medical Officer
Open-market sale
$128.61 per share
27,173 shares
SEC Form 4
23
Jul 2026
Lewis William
Director, Chair and CEO
Option exercise
$24.94 per share
10,700 shares
SEC Form 4
23
Jul 2026
Lewis William
Director, Chair and CEO
Open-market sale
$106.06 per share
10,700 shares
SEC Form 4

Top Shareholders

Vanguard Group Inc
21,076,344 shares
5.721% change
12/31/2025
Fmr Llc
16,143,583 shares
22.67% change
6/30/2026
Blackrock, Inc.
15,807,984 shares
-5.217% change
6/30/2026
Jpmorgan Chase & Co
10,428,170 shares
-56.82% change
6/30/2026
Vanguard Portfolio Management Llc
10,407,962 shares
0.349% change
6/30/2026
Vanguard Capital Management Llc
9,790,865 shares
1.543% change
6/30/2026
Baker Bros. Advisors Lp
8,796,111 shares
18.528% change
6/30/2026
Capital International Investors
8,238,124 shares
47.236% change
6/30/2026
Darwin Global Management, Ltd.
6,431,163 shares
-61.731% change
6/30/2026
Ameriprise Financial Inc
6,179,571 shares
102.097% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 17 hours ago